Alpha Windward’s Haemonetics HAE Stock Holding History

Alpha Windward’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-235	Closed	-$30K	–	422
2019 Q3	$30K	Hold	235	–	–	0.02%	309
2019 Q2	$29K	Buy	+235	New	+$23.1K	0.02%	318

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha Windward's HAE Position: Q4 2019 in Review

Alpha Windward sold out of Haemonetics (HAE) in Q4 2019, closing a stake of 235 shares — an estimated $30K sold.

Alpha Windward first reported a position in HAE in Q2 2019 and held it in 2 quarters. The position peaked at $30K in Q3 2019. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

Alpha Windward reported no remaining Haemonetics position as of Q4 2019 after selling out during the quarter.
Alpha Windward sold 235 Haemonetics shares in Q4 2019, an estimated $30K.
Alpha Windward first reported a position in Haemonetics in Q2 2019 and held it in 2 quarters.
Alpha Windward's Haemonetics position peaked at $30K in Q3 2019.
298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Alpha Windward's 13F filing for Q4 2019, filed 14 Jan 2020.